What the Options Market Tells Us About Soleno Therapeutics
Whales with a lot of money to spend have taken a noticeably bullish stance on Soleno Therapeutics.
Looking at options history for Soleno Therapeutics SLNO we detected 10 trades.
If we consider the specifics of each trade, it is accurate to state that 70% of the investors opened trades with bullish expectations and 30% with bearish.
From the overall spotted trades, 4 are puts, for a total amount of $265,110 and 6, calls, for a total amount of $523,533.
Projected Price Targets
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $40.0 to $70.0 for Soleno Therapeutics over the recent three months.
Volume & Open Interest Development
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Soleno Therapeutics’s options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Soleno Therapeutics’s whale trades within a strike price range from $40.0 to $70.0 in the last 30 days.
Soleno Therapeutics Option Volume And Open Interest Over Last 30 Days
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SLNO | CALL | TRADE | BEARISH | 01/17/25 | $1.3 | $0.75 | $0.8 | $65.00 | $202.7K | 2.5K | 2.5K |
| SLNO | PUT | TRADE | BULLISH | 01/17/25 | $2.0 | $0.25 | $0.3 | $40.00 | $133.4K | 35.6K | 4.5K |
| SLNO | CALL | TRADE | BULLISH | 12/20/24 | $3.1 | $2.4 | $2.9 | $55.00 | $129.3K | 1.7K | 701 |
| SLNO | CALL | SWEEP | BEARISH | 04/17/25 | $7.5 | $5.2 | $5.2 | $70.00 | $95.2K | 79 | 69 |
| SLNO | PUT | SWEEP | BULLISH | 01/17/25 | $5.0 | $3.0 | $3.0 | $55.00 | $76.8K | 162 | 262 |
About Soleno Therapeutics
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.
Having examined the options trading patterns of Soleno Therapeutics, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
Present Market Standing of Soleno Therapeutics
- Currently trading with a volume of 1,138,044, the SLNO’s price is up by 1.58%, now at $58.12.
- RSI readings suggest the stock is currently may be approaching overbought.
- Anticipated earnings release is in 99 days.
Professional Analyst Ratings for Soleno Therapeutics
2 market experts have recently issued ratings for this stock, with a consensus target price of $71.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge’s Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.
* An analyst from Oppenheimer has decided to maintain their Outperform rating on Soleno Therapeutics, which currently sits at a price target of $73.
* Reflecting concerns, an analyst from HC Wainwright & Co. lowers its rating to Buy with a new price target of $70.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Soleno Therapeutics with Benzinga Pro for real-time alerts.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Leave a Reply